VNDA Smart Money
Vanda Pharmaceuticals Inc.
1W: -3.7%
1M: -22.0%
3M: -23.6%
YTD: -52.2%
1Y: -28.2%
3Y: -8.6%
5Y: -78.2%
$3.99
+0.05 (+1.27%)
After Hours: $3.94 (-0.06, -1.38%)
Weekly Expected Move ±5.0%
$4
$4
$4
$4
$4
Credit Risk of going bust: higher than 65% of companies Debt: 8.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.06 (down 99%), Vanda Pharmaceuticals Inc. would be worth roughly what it owes.
Total debt $22.8M against a stock market value of $238.2M.
Distance to default 3.79 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $11.4M (short-term plus half of long-term), stock volatility 78.5%; Altman Z'' -4.18. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.06 (down 99%), Vanda Pharmaceuticals Inc. would be worth roughly what it owes.
Total debt $22.8M against a stock market value of $238.2M.
Distance to default 3.79 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $11.4M (short-term plus half of long-term), stock volatility 78.5%; Altman Z'' -4.18. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026198
Institutions Holding
-3 vs prior
122.3%
Ownership
-4.79%
30
New
68
Increased
80
Reduced
25
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | Chrousos Phaedra | director | A-Grant/Award | 41,600 | $— | $0 | Filing |
| 2026-06-04 | Mitchell Stephen Ray | director | A-Grant/Award | 41,600 | $— | $0 | Filing |
| 2026-06-04 | Honore Tage | director | A-Grant/Award | 41,600 | $— | $0 | Filing |
| 2026-06-04 | Ward Anne Sempowski | director | A-Grant/Award | 41,600 | $— | $0 | Filing |
| 2026-06-04 | DUGAN RICHARD W | director | A-Grant/Award | 41,600 | $— | $0 | Filing |
| 2026-06-04 | Duncan Charles Cliff | director | A-Grant/Award | 41,600 | $— | $0 | Filing |
| 2026-06-04 | McGuire Daniel Patrick | officer: svp, gc and secretary | A-Grant/Award | 80,000 | $— | $0 | Filing |
| 2026-05-18 | Mitchell Stephen Ray | director | G-Gift | 25,836 | $— | $0 | Filing |
| 2026-03-02 | Williams Timothy | officer: svp & general counsel | S-Sale | 42,434 | $8.27 | $351K | Filing |
| 2026-03-02 | Moran Kevin Patrick | officer: svp, cfo & treasurer | S-Sale | 42,442 | $8.27 | $351K | Filing |
| 2026-03-02 | Wijkstrom Joakim | officer: svp, chief marketing officer | S-Sale | 30,800 | $8.27 | $255K | Filing |
| 2026-03-02 | Polymeropoulos Mihael Hristos | officer: president and ceo | S-Sale | 156,235 | $8.17 | $1.3M | Filing |
| 2026-03-02 | Birznieks Gunther | officer: svp, business development | S-Sale | 42,431 | $8.27 | $351K | Filing |
| 2026-02-23 | Honore Tage | director | S-Sale | 30,000 | $8.03 | $241K | Filing |
| 2026-02-18 | Williams Timothy | officer: svp & general counsel | A-Grant/Award | 125,000 | $— | $0 | Filing |
| 2026-02-18 | Wijkstrom Joakim | officer: svp, chief marketing officer | A-Grant/Award | 125,000 | $— | $0 | Filing |
| 2026-02-18 | Polymeropoulos Mihael Hristos | officer: president and ceo | A-Grant/Award | 525,000 | $— | $0 | Filing |
| 2026-02-18 | Moran Kevin Patrick | officer: svp, cfo & treasurer | A-Grant/Award | 125,000 | $— | $0 | Filing |
| 2026-02-18 | Birznieks Gunther | officer: svp, business development | A-Grant/Award | 125,000 | $— | $0 | Filing |
| 2025-08-07 | Polymeropoulos Mihael Hristos | officer: president and ceo | P-Purchase | 10,000 | $4.15 | $42K | Filing |
| 2025-06-13 | Mitchell Stephen Ray | director | S-Sale | 7,000 | $4.59 | $32K | Filing |
| 2025-06-05 | Mitchell Stephen Ray | director | A-Grant/Award | 59,225 | $— | $0 | Filing |
| 2025-06-05 | Ward Anne Sempowski | director | A-Grant/Award | 59,225 | $— | $0 | Filing |
| 2025-06-05 | Honore Tage | director | A-Grant/Award | 59,225 | $— | $0 | Filing |
| 2025-06-05 | DUGAN RICHARD W | director | A-Grant/Award | 59,225 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7,653,737 | $47M | +377,749 | 2026-06-30 | Filing |
| STATE STREET CORP | 3,516,405 | $22M | +500,843 | 2026-06-30 | Filing |
| AQR CAPITAL MANAGEMENT LLC | 3,497,695 | $21M | +1,894,119 | 2026-06-30 | Filing |
| RENAISSANCE TECHNOLOGIES LLC | 3,441,361 | $21M | -318,198 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,524,040 | $15M | +42,549 | 2026-06-30 | Filing |
| AIGH Capital Management LLC | 2,044,169 | $13M | -705,831 | 2026-06-30 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 1,727,349 | $11M | -44,244 | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 1,602,813 | $10M | -278,188 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,483,787 | $9M | +40,822 | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 1,349,072 | $8M | -49,129 | 2026-06-30 | Filing |
| MARSHALL WACE, LLP | 1,225,996 | $8M | +629,994 | 2026-06-30 | Filing |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,213,326 | $7M | +44,645 | 2026-06-30 | Filing |
| Krensavage Asset Management, LLC | 1,180,388 | $7M | — | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,131,034 | $7M | +116,512 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 1,036,260 | $6M | +198,027 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 758,302 | $5M | +124,948 | 2026-06-30 | Filing |
| Qube Research & Technologies Ltd | 729,212 | $4M | +729,212 | 2026-06-30 | Filing |
| FEDERATED HERMES, INC. | 714,278 | $4M | +138,889 | 2026-06-30 | Filing |
| Sixth Street Partners Management Company | 646,256 | $4M | +646,256 | 2026-06-30 | Filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 646,256 | $4M | +94,486 | 2026-06-30 | Filing |